The heparin management test: A new device for monitoring anticoagulation during coronary intervention

Whole blood coagulation analysers are widely used during percutaneous coron ary interventions. The precise degree of anticoagulation in patients is imp ortant in this setting. The aim of this investigation was to compare the re sults obtained with ACT (Hemochron) and HMT, the Heparin Management Test (T AS) in patients undergoing percutaneous coronary interventions. Patients (n =100) were enrolled prospectively. Each patient received 10,000 units of he parin, At the end of the procedure, the mean ACT was 284+/-31 seconds and t he mean HMT was 292+/-33 seconds. The correlation between the two methods w as highly significant (r=0.64, p<0.001). The HMT correlates well with ACT v alues in patients undergoing percutaneous coronary interventions. Its use i n the management of these patients should be considered.